SMTL ID : 6o3i.1 (1 other biounit)

Crystal Structure of Human IDO1 bound to navoximod (NLG-919)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.69 Å

Oligo State

monomer

Ligands

1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 23 residues within 4Å: Chain A: Y.141, F.178, V.181, S.182, V.185, F.229, I.232, F.241, S.278, A.279, G.280, F.285, F.306, R.358, H.361, I.364, V.365, Y.368, I.369, F.402, L.403, V.406 Ligands: LKP.2 20 PLIP interactions: 20 interactions with chain A, Hydrophobic interactions: A:F.178, A:V.181, A:V.185, A:F.229, A:F.229, A:I.232, A:F.241, A:A.279, A:F.285, A:F.285, A:I.364, A:V.365, A:Y.368, A:Y.368, A:F.402, A:L.403 Hydrogen bonds: A:A.279 Salt bridges: A:R.358 pi-Stacking: A:H.361 Metal complexes: A:H.361

1 x LKP: trans-4-{(1R)-2-[(5S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl}cyclohexan-1-ol(Non-covalent)

LKP.2: 13 residues within 4Å: Chain A: Y.141, C.144, V.145, F.178, F.179, S.182, R.246, L.249, S.250, G.277, S.278, A.279 Ligands: HEM.1 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:Y.141, A:V.145, A:F.178, A:F.179, A:F.179, A:L.249, A:L.249 Hydrogen bonds: A:R.246

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kumar, S. et al., Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1. J.Med.Chem. (2019)

Release Date

2019-07-17

Peptides

Indoleamine 2,3-dioxygenase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Indoleamine 2,3-dioxygenase 1

Related Entries With Identical Sequence